Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa. (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci.insight.126243

PubMed Identifier: 31167965

Publication URI: http://europepmc.org/abstract/MED/31167965

Type: Journal Article/Review

Volume: 4

Parent Publication: JCI insight

Issue: 11

ISSN: 2379-3708